Financial Impact of Cancer Treatment on Families Post-ACA

Soumitra Bhuyan, an expert with the Edward J. Bloustein School of Planning and Public Policy, participated in research exploring the financial impact of cancer treatment costs on families post-Affordable Care Act (ACA). Although some demographics experienced a reduction in out-of-pocket expenses, the overall income burden for families impacted by cancer has not shown significant improvement since the ACA was enacted.

Cancer remains a leading cause of mortality in the United States, imposing a substantial financial strain on individuals and families. The ACA aimed to improve healthcare affordability, especially for costly treatments. Bhuyan observed a notable decrease in out-of-pocket expenses, particularly among the lowest and second-lowest income brackets, with reductions of 48.3% and 51.5% respectively. However, the persistent financial strain due to cancer treatment continues to affect family income adversely.

Healthcare spending in the nation amounts to approximately 18% of GDP per capita, yet many still face challenges accessing adequate healthcare resources. Insurance access plays a vital role, as a significant percentage of Americans lacked health insurance prior to the ACA implementation.

Assessing ACA's Impact on Cancer Treatment Costs

The research leveraged data from the Medical Expenditure Panel Survey (MEPS) to analyze healthcare costs for cancer patients aged 18 to 64, focusing on transformations from 2010 to 2019. Particular attention was given to 2014, when key ACA provisions were introduced, to evaluate their impact. Findings indicate a persistent gap between medical coverage and financial protection, as rising cancer care costs continue to cause financial distress, often termed "financial toxicity."

Bhuyan suggested that healthcare organizations might restructure to better manage escalating treatment costs. The study also highlights the importance of financial education and literacy to effectively navigate insurance complexities. Despite expanded insurance coverage under the ACA, many patients struggle with understanding intricate elements like benefit design and cost-sharing structures.

A study limitation is its national data scope, which omits state-specific insurance premiums and Medicaid policy variations. Bhuyan recommended future research focuses on the role of financial education in alleviating cancer treatment's financial pressures. He emphasized the importance of understanding insurance plans, particularly around critical, life-changing events.